NEOGENOMICS INC — Director's Dealing 2021

Dec 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-11-30

Reporting Person: Bonello William (President, Informatics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-30	Common Stock	M	25000	$7.52	Acquired	40473	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-30	Stock Option (Right to Buy)	$7.52	M	25000	Disposed	2022-04-28	Common Stock (25000.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (45370.0)	45370	Direct
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (41167.0)	41167	Direct
Stock Option (Right to Buy)	$28.33	2027-03-02	Common Stock (37514.0)	37514	Direct
Stock Option (Right to Buy)	$53.17	2028-03-02	Common Stock (24619.0)	24619	Direct

Footnotes

F1: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F2: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F3: On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date

F4: On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F5: On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.